Cite
MLA Citation
Akito Hata et al.. “Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLE.” Journal of clinical oncology, vol. 40, no. 2, 2022, pp. 180–188. http://access.bl.uk/ark:/81055/vdc_100150609950.0x000025